Browse By Last Name
Howard Zhang

Mr. Zhang is a partner in Davis Polk’s Corporate Department, resident in Beijing. He focuses on mergers and acquisitions, including private equity portfolio investments, buyouts, joint ventures and strategic investment transactions. He also advises clients on cross-border securities and general corporate matters.

Work Highlights

  • IDG Capital, together with China Oceanwide on its acquisition of International Data Group

  • The Buyer Group on the going-private transactions of KongZhong and Synutra

  • Special committee of Origin Agritech Limited on its sale of commercial seed production and distribution business

  • Ingram Micro’s $6 billion acquisition by Tianjin Tianhai to become part of HNA Group
  • Huatai Securities’ $780 million acquisition of AssetMark
  • Freeport-McMoRan’s sale of its interest in TF Holdings to China Molybdenum for $2.65 billion

  • Fujian Thai Hot Investment's:

    • $1.4 billion acquisition of the insurance operations of Hong Kong-based financial services firm Dah Sing
    • Acquisition of a majority interest in Alliance HealthCare Services
  • CNOOC’s $17.9 billion acquisition of Nexen

  • Postal and Savings Bank of China's $7 billion sale of shares to strategic investors
  • Dalian Wanda’s $2.6 billion acquisition of AMC Entertainment
  • Baidu’s:
    • $1.9 billion acquisition of 91 Wireless Websoft Limited
    • $370 million acquisition of the online video business of PPS
    • $306 million investment in Qunar
    • Investment in Cheetah Mobile
    • Acquisition of providence equity partners’ stake in iQiyi
    • Series B financing of
  • IDG Capital Partners' investment in DMALL and SouFun
  • Warburg Pincus, Hillhouse Capital and Standard Chartered Private Equity's joint investment in ZTO Express
  • Warburg Pincus in its:
    • Acquisition of a majority stake in Beijing Fanhua Datong Investment Management Company
    • Agreement to acquire a significant stake in China Biological Products, a Nasdaq-listed company
  • Special committee of on its acquisition by Baihe
  • Charles River Laboratory International’s proposed agreement to acquire Wuxi Pharmatech for $1.6 billion
  • A consortium led by the management team of Amdocs China and IDG Capital Partners in its agreement to acquire the China operations from Amdocs, a Nasdaq-listed company
  • IDG Capital Partners and the management team in its acquisition of a controlling stake in Kongzhong, a wireless value-added service provider listed on Nasdaq
  • COFCO’s investment in Smithfield Foods
  • Baring Private Equity Asia in financing a management buyout of Asian American Gas
  • CCMP Asia’s acquisition of the flue gas desulphurization business from a publicly listed company in China
  • Merrill Lynch on several investments in China
  • Yahoo’s acquisition of a Chinese search engine
  • Focus Media’s acquisition of Framedia and Allyes Information Technology
  • Shanda’s acquisition of a significant stake in Sina
  • Qiyi’s $400 million pre-IPO financing
  • Unitas Capital on its acquisition of a majority stake in ZTE NetView
  • Synutra in a partnership agreement with Sodiaal
  • IDG Ventures in connection with privatization of Soko Fitness & Spa Group
  • Stable Investment Corporation on its investment in China Lumena New Materials
Capital Markets
  • People's Insurance Company (Group) of China on its $3.6 billion Hong Kong IPO and global offering – the largest Hong Kong IPO for 2011 and 2012
  • New China Life Insurance Company Ltd. on its $1.9 billion IPO
  • Agricultural Bank of China Limited on its $22.1 billion global offering and dual listing in Hong Kong and Shanghai
  • China Nonferrous Mining Corporation Limited on its $252 million Hong Kong IPO and global offering
  • Nexteer Automotive Group Limited on its US$260 million initial public offering
  • The underwriters on:
    • AAG Energy's $294 million Hong Kong IPO 
    • China Unicom’s convertible bonds offering
    • China Xueda’s SEC-registered initial public offering
    • ChinaCache’s SEC-registered initial public offering
    • 21 Vianet Group’s SEC-registered initial public offering
    • China Synergy’s SEC-registered initial public offering
  • iKang Healthcare Group, Inc. on its $152.7 million IPO and $40 million concurrent private placement
  • Zhaopin Limited initial public offering and NYSE listing
  • China Lodging’s SEC-registered initial public offering
  • Acorn International’s SEC-registered initial public offering
  • China Finance Online SEC-registered initial public offering
  • ATA’s SEC-registered initial public offering
  • Shanda Interactive Entertainment’s SEC-registered initial public offering
  • Mengniu on its $500 million bond offering
  • iKang on its issuance and sale of US$100 million of preferred stock


Mr. Zhang is recognized as a leading lawyer in various industry publications:

  • Chambers Global
  • Chambers Asia-Pacific
  • IFLR1000
  • Expert Guide to the World’s Leading Private Equity Lawyers

Of Note

  • Member, Dean’s Advisory Board, Boston University Law School


  • 2201 China World Office 2
    1 Jian Guo Men Wai Avenue
    Chaoyang District
    P: +86 10 8567 5002
    F: +86 10 8567 5102

Bar Admissions

  • Commonwealth of Massachusetts
  • Beijing Ministry of Justice - Registered


  • B.A., Shanghai International Studies University, 1981
  • J.D., Boston University School of Law, 1993
    • American Jurisprudence Award
    • Topics Editor, International Law Journal


  • Mandarin
  • English